Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic
Language: English
Published by Humana Press, 2000
- Hardcover
- New

Seller: Revaluation Books, Exeter, United KingdomRevaluation Books
AbeBooks seller since January 6, 2003
Condition: New
US$ 360.12
Quantity: 2 available
Add to basketItem description from seller
528 pages. 10.50x7.50x1.25 inches. In Stock.
Seller Inventory # x-089603724X
- Title
- Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic
- Author
- Emerich, Dwaine F. (Edited by)/ Dean III, Reginald L. (Edited by)/ Sanberg, Paul R. (Edited by)
- Publisher
- Humana Press
- Publication year
- 2000
- Condition
- Brand New
- Binding
- Hardcover
- Language
- English
- ISBN 10
- 089603724X
- ISBN 13
- 9780896037243
- Item weight
- 2.69 kilograms
"Synopsis" may belong to another edition of this title.
From the Back Cover
Comprehensive and authoritative, Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic offers neuroscientists, pharmacologists, and interested clinicians a unique survey of the most productive animal models of the leading neurological diseases currently employed to develop today's innovative drug therapies.
"About the title" may belong to another edition of this title.
Revaluation Books
Exeter, United Kingdom
AbeBooks seller since January 6, 2003
Shipping rates from United Kingdom to U.S.A.
| Item | 2 to 3 business days | 7 to 14 business days |
|---|---|---|
| First item | US$ 46.93 | US$ 46.93 |
Payment methods
Seller's business information
Edward Bowditch Ltd
Exstowe, Exton
Exeter, United Kingdom EX3 0PP
Terms of sale
Legal entity name: Edward Bowditch Ltd
Legal entity form: Limited company
Business correspondence address: Exstowe, Exton, Exeter, EX3 0PP
Company registration number: 04916632
VAT registration: GB834241546
Authorised representative: Mr. E. Bowditch
Shipping terms
Orders usually dispatched within two working days. Please note that at this time all domestic United Kingdom orders are sent by trackable UPS courier, we choose not to offer a lower cost alternative.